Life Sciences

Finding sustainability in biotechnology, pharmaceutical and medical technology

Amplified business decisions are the new norm thanks to rapid changes. From new market entrants and regulatory reform to expiring patents and the growing challenge of chronic diseases, leaders in the life sciences community must explore a new course to address the changing climate for health care — one driven by patients and focused on health outcomes.

Our Global Life Sciences Center brings together a worldwide team of professionals to help you achieve your potential.

We cover key issues in these areas:

Connect with us

Stay connected with us through social media, email alerts or webcasts. Or download our EY Insights app for mobile devices.

EY - Deal Outlook 2015 webcast

You're invited - Deal Outlook 2015 webcast

Join us 11 February for an informative session on current deal drivers, market trends and a 2015 deal outlook for various sectors, including life sciences.

Related Content

Financial reporting briefs – life sciences (March 2014)

EY - Financial reporting briefs life sciences

This edition highlights the latest developments in financial reporting for the life sciences industry and alerts you to some important considerations for 2014.

First-time visitors will be prompted to complete a brief registration form to access the AccountingLink site where the above publication resides.